Pacira Pharmaceuticals reported $61.28M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 5.26M 1.56M
Amerisourcebergen ABC:US USD 1.26B 51.31M
Astellas Pharma 4503:JP JPY 154.56B 1.16B
Bristol Myers Squibb BMY:US USD 1.93B 147M
Cara Therapeutics CARA:US USD 6.88M 658K
Coherus Biosciences CHRS:US USD 44.83M 6.44M
Depomed DEPO:US USD 11.9M 1.56M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Horizon Pharma HZNP:US USD 397.56M 658K
Ironwood Pharmaceuticals IRWD:US USD 28.62M 1.5M
Johnson & Johnson JNJ:US USD 6.51B 423M
Lannett LCI:US USD 16.7M 9.06M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Omeros OMER:US USD 12.2M 1.72M
Pacira Pharmaceuticals PCRX:US USD 61.28M 3.72M
Perrigo Ordinary Shares PRGO:US USD 281M 57.1M
Pfizer PFE:US USD 4.87B 1.33B
Revance Therapeutics RVNC:US USD 64.09M 17.91M
Supernus Pharmaceuticals SUPN:US USD 224.63M 124.15M
Teva Pharmaceutical TEVA:IT USD 777M 72M
Xeris Pharmaceuticals Inc XERS:US USD 34.49M 1.51M
Xoma XOMA:US USD 4.79M 916K
Zoetis ZTS:US USD 501M 28M